Release Date: 19/10/12 10:07 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 46.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%